Newsbenzinga
B. Riley Securities Initiates Coverage On Ascentage Pharma Group with Buy Rating, Announces Price Target of $45
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Comments —
Loading comments…